BACKGROUND: Although effective, current chimeric antigen receptor T-cell (CAR-T) production methods-centralized, manual, and complex-are cost-intensive, time-consuming, and prone to variability. AIDPATH (AI-Powered Decentralized Production for Advanc...
read more